Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Payables (2016 - 2025)

Historic Payables for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $6.2 million.

  • Innoviva's Payables rose 4971.22% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 4971.22%. This contributed to the annual value of $2.1 million for FY2024, which is 6825.96% down from last year.
  • Latest data reveals that Innoviva reported Payables of $6.2 million as of Q3 2025, which was up 4971.22% from $5.4 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Payables peaked at $6.7 million during Q4 2023, and registered a low of $14000.0 during Q1 2021.
  • Over the past 5 years, Innoviva's median Payables value was $3.8 million (recorded in 2023), while the average stood at $3.1 million.
  • Per our database at Business Quant, Innoviva's Payables crashed by 8852.46% in 2021 and then surged by 1431000.0% in 2022.
  • Innoviva's Payables (Quarter) stood at $27000.0 in 2021, then soared by 10785.19% to $2.9 million in 2022, then skyrocketed by 128.55% to $6.7 million in 2023, then crashed by 68.26% to $2.1 million in 2024, then surged by 192.82% to $6.2 million in 2025.
  • Its last three reported values are $6.2 million in Q3 2025, $5.4 million for Q2 2025, and $4.7 million during Q1 2025.